{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:11:58Z","timestamp":1791090718208,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2000,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.ccr.2008.01.030","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T15:56:11Z","timestamp":1205337371000},"page":"261-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["A Conditional Mouse Model for Malignant Mesothelioma"],"prefix":"10.1016","volume":"13","author":[{"given":"Johan","family":"Jongsma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"van Montfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vooijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Zevenhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Krimpenfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"van der Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"van de Vijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Berns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2008.01.030_bib1","first-page":"1209","article-title":"Mesothelial cell proliferation after instillation of long or short asbestos fibers into mouse lung","volume":"142","author":"Adamson","year":"1993","journal-title":"Am. J.\u00a0Pathol."},{"key":"10.1016\/j.ccr.2008.01.030_bib2","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1101\/gad.1158703","article-title":"Activated Kras and Ink4a\/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma","volume":"17","author":"Aguirre","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2008.01.030_bib3","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/nar\/25.9.1766","article-title":"Cre-mediated somatic site-specific recombination in mice","volume":"25","author":"Akagi","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccr.2008.01.030_bib4","doi-asserted-by":"crossref","first-page":"8090","DOI":"10.1158\/0008-5472.CAN-05-2312","article-title":"A mouse model recapitulating molecular features of human mesothelioma","volume":"65","author":"Altomare","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2008.01.030_bib5","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1128\/jvi.69.8.4600-4606.1995","article-title":"Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: A molecular switch for control of gene expression","volume":"69","author":"Anton","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.ccr.2008.01.030_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0165-4608(00)00420-9","article-title":"DNA copy number changes in familial malignant mesothelioma","volume":"127","author":"Ascoli","year":"2001","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.ccr.2008.01.030_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1365-2559.2000.00981.x","article-title":"Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms","volume":"37","author":"Attanoos","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.ccr.2008.01.030_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1212\/WNL.59.2.290","article-title":"Neurofibromatosis 2 and malignant mesothelioma","volume":"59","author":"Baser","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ccr.2008.01.030_bib9","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","article-title":"High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas","volume":"92","author":"Bianchi","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2008.01.030_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng0294-185","article-title":"Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types","volume":"6","author":"Bianchi","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccr.2008.01.030_bib11","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1242\/jcs.114.10.1901","article-title":"Normal membrane localization and actin association of the NF2 tumor suppressor protein are dependent on folding of its N-terminal domain","volume":"114","author":"Brault","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ccr.2008.01.030_bib12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/ajcp\/92.5.566","article-title":"Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms","volume":"92","author":"Cagle","year":"1989","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ccr.2008.01.030_bib13","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm0897-908","article-title":"Simian virus-40 large-T antigen binds p53 in human mesotheliomas","volume":"3","author":"Carbone","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2008.01.030_bib14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00000478-198810000-00002","article-title":"Three types of spindle cell tumors of the pleura. Fibroma, sarcoma, and sarcomatoid mesothelioma","volume":"12","author":"Carter","year":"1988","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccr.2008.01.030_bib15","first-page":"5547","article-title":"p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma","volume":"54","author":"Cheng","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2008.01.030_bib16","first-page":"1524","article-title":"SV40 induces mesotheliomas in hamsters","volume":"142","author":"Cicala","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccr.2008.01.030_bib17","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1097\/00001756-199510020-00028","article-title":"Widespread but cell type-specific expression of the mouse neurofibromatosis type 2 gene","volume":"6","author":"Claudio","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.ccr.2008.01.030_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/geno.1994.1291","article-title":"The mouse neurofibromatosis type 2 gene maps to chromosome 11","volume":"21","author":"Claudio","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.ccr.2008.01.030_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/hmg\/3.1.185","article-title":"The mouse homologue of the neurofibromatosis type 2 gene is highly conserved","volume":"3","author":"Claudio","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ccr.2008.01.030_bib20","first-page":"448","article-title":"Characteristics of tumors and tumor cells cultured from experimental asbestos-induced mesotheliomas in rats","volume":"129","author":"Craighead","year":"1987","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccr.2008.01.030_bib21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nm0897-913","article-title":"The retinoblastoma gene family pRb\/p105, p107, pRb2\/p130 and simian virus-40 large T-antigen in human mesotheliomas","volume":"3","author":"De Luca","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2008.01.030_bib22","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1038\/sj.onc.1204828","article-title":"Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma","volume":"20","author":"De Rienzo","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2008.01.030_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/hmg\/7.2.217","article-title":"Impaired interaction of naturally occurring mutant NF2 protein with actin-based cytoskeleton and membrane","volume":"7","author":"Deguen","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ccr.2008.01.030_bib24","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/1097-4547(20001215)62:6<764::AID-JNR2>3.0.CO;2-V","article-title":"Evidence for a cytoskeleton attachment domain at the N-terminus of the NF2 protein","volume":"62","author":"den Bakker","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ccr.2008.01.030_bib25","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1038\/sj.onc.1206593","article-title":"Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours","volume":"22","author":"Fleury-Feith","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2008.01.030_bib26","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1101\/gad.13.8.978","article-title":"Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein","volume":"13","author":"Giovannini","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2008.01.030_bib27","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1101\/gad.14.13.1617","article-title":"Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2","volume":"14","author":"Giovannini","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2008.01.030_bib28","first-page":"M29","article-title":"Merlin: The\u00a0neurofibromatosis 2 tumor suppressor","volume":"1423","author":"Gusella","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ccr.2008.01.030_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/hmg\/7.3.335","article-title":"Defects in neurofibromatosis 2 protein function can arise at multiple levels","volume":"7","author":"Gutmann","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ccr.2008.01.030_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/hmg\/8.2.267","article-title":"Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading","volume":"8","author":"Gutmann","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ccr.2008.01.030_bib31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjc.6602307","article-title":"The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050","volume":"92","author":"Hodgson","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccr.2008.01.030_bib32","first-page":"121","article-title":"Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium)","volume":"13","author":"Hubner","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ccr.2008.01.030_bib33","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1101\/gad.943001","article-title":"Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras","volume":"15","author":"Jackson","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2008.01.030_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc777","article-title":"Conditional mouse models of sporadic cancer","volume":"2","author":"Jonkers","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2008.01.030_bib35","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ng747","article-title":"Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer","volume":"29","author":"Jonkers","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccr.2008.01.030_bib36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1309\/7ECY-KN61-PP1M-52EB","article-title":"Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma","volume":"113","author":"Khalidi","year":"2000","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ccr.2008.01.030_bib37","doi-asserted-by":"crossref","first-page":"10394","DOI":"10.1074\/jbc.M200083200","article-title":"Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization","volume":"277","author":"Kissil","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccr.2008.01.030_bib38","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.92.24.10819","article-title":"Asbestos and mesothelioma: Genetic lessons from a tragedy","volume":"92","author":"Knudson","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2008.01.030_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/35092584","article-title":"Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice","volume":"413","author":"Krimpenfort","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2008.01.030_bib40","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1093\/nar\/19.15.4293","article-title":"Simplified mammalian DNA isolation procedure","volume":"19","author":"Laird","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccr.2008.01.030_bib41","first-page":"1061","article-title":"Oncogenes and tumor-suppressor genes in mesothelioma\u2013a synopsis","volume":"105","author":"Lechner","year":"1997","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ccr.2008.01.030_bib42","first-page":"181","article-title":"Somatic genetic alterations in human malignant mesothelioma","volume":"14","author":"Lee","year":"1999","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ccr.2008.01.030_bib43","first-page":"6455","article-title":"Chromosomal translocations with specific breakpoints in asbestos-induced rat mesotheliomas","volume":"48","author":"Libbus","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2008.01.030_bib44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1165\/ajrcmb.23.3.4094","article-title":"Phagocytosis of crocidolite asbestos induces oxidative stress, DNA damage, and apoptosis in mesothelial cells","volume":"23","author":"Liu","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ccr.2008.01.030_bib45","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.161269798","article-title":"Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells","volume":"98","author":"Loonstra","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2008.01.030_bib46","first-page":"1159","article-title":"Evidence against the role for SV40 infection in human mesothelioma and high risk of false positive PCR results owing to the presence of SV40 sequences in common laboratory plasmids","volume":"364","author":"Lopos-Rios","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ccr.2008.01.030_bib47","first-page":"7042","article-title":"The generation of a conditional reporter that enables bioluminescence imaging of Cre\/loxP-dependent tumorigenesis in mice","volume":"63","author":"Lyons","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2008.01.030_bib48","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1101\/gad.14.8.994","article-title":"Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum","volume":"14","author":"Marino","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2008.01.030_bib49","first-page":"1069","article-title":"Susceptibility of p53-deficient mice to induction of mesothelioma by crocidolite asbestos fibers","volume":"105","author":"Marsella","year":"1997","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ccr.2008.01.030_bib50","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1101\/gad.12.8.1121","article-title":"Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors","volume":"12","author":"McClatchey","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2008.01.030_bib51","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1101\/gad.11.10.1253","article-title":"The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation","volume":"11","author":"McClatchey","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2008.01.030_bib52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/excr.2000.5146","article-title":"Mouse Models for Sporadic Cancer","volume":"264","author":"Meuwissen","year":"2001","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ccr.2008.01.030_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1165\/ajrcmb.16.1.8998073","article-title":"Absence of p53 mutations in malignant mesotheliomas","volume":"16","author":"Mor","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ccr.2008.01.030_bib54","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.189601","article-title":"The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44","volume":"15","author":"Morrison","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2008.01.030_bib55","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1158\/0008-5472.CAN-06-1608","article-title":"Merlin\/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac","volume":"67","author":"Morrison","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2008.01.030_bib56","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1097-4652(199908)180:2<150::AID-JCP2>3.0.CO;2-H","article-title":"Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma","volume":"180","author":"Murthy","year":"1999","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ccr.2008.01.030_bib57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ajcp\/112.1.75","article-title":"Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma. Review and update","volume":"112","author":"Ordonez","year":"1999","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ccr.2008.01.030_bib58","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/00000478-199712000-00016","article-title":"Malignant peripheral nerve sheath tumor of the pleura with epithelial and rhabdomyoblastic differentiation: Report of a case clinically simulating mesothelioma","volume":"21","author":"Ordonez","year":"1997","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccr.2008.01.030_bib59","first-page":"425","article-title":"Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas","volume":"18","author":"Papp","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ccr.2008.01.030_bib60","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1038\/sj.onc.1209587","article-title":"Re-expression of the tumor suppressor NF2\/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK","volume":"25","author":"Poulikakos","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2008.01.030_bib61","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<649::AID-IJC25>3.0.CO;2-2","article-title":"The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma","volume":"75","author":"Prins","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ccr.2008.01.030_bib62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/scbi.2000.0347","article-title":"SV40 and the pathogenesis of mesothelioma","volume":"11","author":"Rizzo","year":"2001","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ccr.2008.01.030_bib63","doi-asserted-by":"crossref","first-page":"10786","DOI":"10.1158\/0008-5472.CAN-05-4668","article-title":"A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: Malignant transformation is dose dependent","volume":"66","author":"Robinson","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2008.01.030_bib64","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2008.01.030_bib65","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1242\/jcs.110.18.2249","article-title":"Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton","volume":"110","author":"Sainio","year":"1997","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ccr.2008.01.030_bib66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-4608(01)00432-0","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors","volume":"127","author":"Sandberg","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.ccr.2008.01.030_bib67","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/carcin\/21.5.1023","article-title":"mRNA expression patterns in different stages of asbestos-induced carcinogenesis in rats","volume":"21","author":"Sandhu","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ccr.2008.01.030_bib68","first-page":"1227","article-title":"Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer","volume":"55","author":"Sekido","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2008.01.030_bib69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","article-title":"Role of the INK4a locus in tumor suppression and cell mortality","volume":"85","author":"Serrano","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2008.01.030_bib70","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1038\/sj.onc.1206461","article-title":"The INK4a\/ARF locus and melanoma","volume":"22","author":"Sharpless","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2008.01.030_bib71","first-page":"2761","article-title":"p16(INK4a) and p53 deficiency cooperate in tumorigenesis","volume":"62","author":"Sharpless","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2008.01.030_bib72","first-page":"287","article-title":"Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin","volume":"9","author":"Shaw","year":"1998","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.ccr.2008.01.030_bib73","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1074\/jbc.273.13.7757","article-title":"Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli","volume":"273","author":"Shaw","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccr.2008.01.030_bib74","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0962-8924(01)02128-6","article-title":"Merlin: Hanging tumor suppression on the Rac","volume":"11","author":"Sherman","year":"2001","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ccr.2008.01.030_bib75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.278.5335.120","article-title":"Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene","volume":"278","author":"Shibata","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ccr.2008.01.030_bib76","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/5007","article-title":"Generalized lacZ expression with the ROSA26 Cre reporter strain","volume":"21","author":"Soriano","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccr.2008.01.030_bib77","first-page":"2135","article-title":"Detection of cellular proteins that interact with the NF2 tumor suppressor gene product","volume":"9","author":"Takeshima","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2008.01.030_bib78","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/bjc.1989.326","article-title":"Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma","volume":"60","author":"Tiainen","year":"1989","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccr.2008.01.030_bib79","doi-asserted-by":"crossref","first-page":"23387","DOI":"10.1016\/S0021-9258(17)31525-9","article-title":"An anti-ras function of neurofibromatosis type 2 gene product (NF2\/Merlin)","volume":"269","author":"Tikoo","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccr.2008.01.030_bib80","first-page":"369","article-title":"Cytology of experimental mesotheliomas induced with crocidolite asbestos","volume":"31","author":"Topov","year":"1987","journal-title":"Acta Cytol."},{"key":"10.1016\/j.ccr.2008.01.030_bib81","first-page":"826","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor","volume":"75","author":"Trofatter","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2008.01.030_bib82","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/embo-reports\/kve064","article-title":"A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent","volume":"2","author":"Vooijs","year":"2001","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ccr.2008.01.030_bib83","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1074\/jbc.C100553200","article-title":"p21-activated kinase links Rac\/Cdc42 signaling to merlin","volume":"277","author":"Xiao","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccr.2008.01.030_bib84","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1128\/MCB.25.6.2384-2394.2005","article-title":"The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression","volume":"25","author":"Xiao","year":"2005","journal-title":"Mol. Cell. Biol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610808000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610808000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:53:50Z","timestamp":1761522830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610808000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1535610808000391"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2008.01.030","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Conditional Mouse Model for Malignant Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccr.2008.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}